Clinical trial
A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for…
NCT00302445 · Derm Research, PLLC, Other · Completed
Key facts
| NCT number | NCT00302445 |
|---|---|
| Title | A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis |
| Official title | An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Raptiva (Efalizumab)in Combination With Narrow Band Phototherapy for the Treatment of Moderate to Severe Plaque Psoriasis. |
| Lead sponsor | Derm Research, PLLC, Other |
| Collaborators | Dermatology Associates, PLLC Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Plaque Psoriasis |
| Intervention type | Device, Drug |
| Interventions | Efalizumab, Narrow Band Phototherapy |
| Enrollment | 20 |
| Start date | Mar 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Mar 14, 2006 |
| Last update posted | Jul 13, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: